Want to join the conversation?
$TOL said it expects interest expensed in cost of sales to be 3.2% of revenues for the full year 2016. Full year 2016 SG&A dollars are anticipated to be 10.4% of full year revenues. The company expects backlog conversion in 3Q16 of roughly 30% on a unit basis and an average delivered price between $815,000-835,000.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?